WillScot
WillScot Declares Quarterly Cash Dividend
WillScot Declares Quarterly Cash Dividend
PHOENIX, May 01, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that its Board of Directors has declared a quarterly dividend of $0.07 per common share. The cash dividend will be paid on June 18, 2025, to shareholders of record as of the close of business on June 4, 2025.
About WillScot
Listed on the Nasdaq stock exchange under the ticker symbol “WSC,” WillScot is the premier provider of highly innovative and turnkey space solutions in North America. The Company’s comprehensive range of products includes modular office complexes, mobile offices, classrooms, temporary restrooms, portable storage containers, protective buildings and climate-controlled units, and clearspan structures, as well as a curated selection of furnishings, appliances, and other supplementary services, ensuring turnkey solutions for its customers. Headquartered in Phoenix, Arizona, and operating from a network of approximately 260 branch locations and additional drop lots across the United States, Canada, and Mexico, WillScot’s business services are essential for diverse customer segments spanning all sectors of the economy.
Additional Information and Where to Find It
Additional information can be found on the company's website at www.willscot.com.
Contact Information
Investor inquiries:
Charlie Wohlhuter
Investors@willscot.com
Media inquiries:
Juliana Welling
Juliana.Welling@willscot.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Equinor ASA2.5.2025 02:29:04 CEST | Press release
Equinor sells the Peregrino field for USD 3.5 billion
Genmab A/S2.5.2025 02:14:12 CEST | Press release
Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Constellation Brands, Inc.1.5.2025 22:30:25 CEST | Press release
Constellation Brands to Present at the 2025 Goldman Sachs Global Staples Forum on May 13, 2025
Mohawk Industries, Inc.1.5.2025 22:15:00 CEST | Press release
Mohawk Industries Reports Q1 Results
WillScot1.5.2025 22:09:47 CEST | Press release
WillScot Reports First Quarter 2025 Results and Reaffirms 2025 Full Year Outlook
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom